WCN26-9388 EFFICACY AND SAFETY OF FINERENONE IN KIDNEY TRANSPLANT RECIPIENTS: A RETROSPECTIVE STUDY

Read full text Summarise with VIRAT
Authors: Fatima AlKindi, Ahmad Chaaban, Amena Abbara, Fatma Shwaylia, Ousama Al Ouda, Kevin T John Keeppallil, Nihal Bashir, Abraham George, M. Al Hakim, Yousef Boobes
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Kidney transplant recipients are at elevated risk for cardiovascular events and progression of chronic kidney disease (CKD). Finerenone, a novel non-steroidal mineralocorticoid receptor antagonist, has demonstrated benefits in patients with CKD and heart failure. However, its safety and efficacy in the transplant population remain insufficiently studied. This study aims to evaluate the clinical outcomes associated with finerenone use in kidney transplant recipients.

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments Hormonal Regulation and Hypertension Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105572–105572
Publication date
25 March 2026
Language
EN